Skip to main content
. 2022 Sep 22;14(19):4604. doi: 10.3390/cancers14194604

Table 3.

Comparisons of the EORTC QLQ-C30 questionnaire scores at the four time points.

EORTC QLO-C30 Pre Treat 30 Days 90 Days 120 Days
(n = 12) (n = 12) (n = 12) (n = 12) p
Component Median [Range] Median [Range] Median [Range] Median [Range] Friedman
Functional scale
Physical functioning 95 [88–100] 92 [83–99] 92 [80–100] 91 [83–96] 0.05
Functioning in social role 92 [67–100] 83 [50–100] 83 [50–100] 67 [50–83] <0.01
Emotional functioning 95 [81–100] 95 [81–100] 94 [90–100] 94 [90–96] 0.97
Cognitive functioning 92 [50–100] 83 [50–100] 83 [67–100] 88 [67–100] 0.48
Social functioning 98 [85–100] 96 [85–100] 93 [81–100] 93 [81–96] 0.32
General quality of life 33 [17–58] 29 [13–42] 25 [8–42] 25 [17–33] 0.77
Symptom scale
Fatigue 11 [0–22] 13 [4–30] 11 [7–33] 15 [11–26] 0.29
Nausea and vomiting 0 [0–8] 0 [0–8] 0 [0–0] 0 [0–0] 0.61
Pain 8 [0–25] 17 [0–33] 8 [0–33] 0 [0–25] 0.22
Dyspnea 0 [0–33] 0 [0–100] 0 [0–33] 0 [0–33] 0.51
Sleeping disturbances 33 [0–67] 17 [0–100] 33 [0–67] 33 [0–33] 0.65
Loss of appetite 0 [0–33] 0 [0–33] 0 [0–33] 0 [0–0] 0.47
Constipation 0 [0–67] 17 [0–67] 0 [0–67] 0 [0–0] 0.45
Diarrhea 0 [0–0] 0 [0–0] 0 [0–0] 0 [0–0] -